Skip to main content

Market Overview

SpringWorks Therapeutics, Inc. - common stock (SWTX)

74.73 0.00 (0.00%)

Analyst Ratings

DateResearch FirmActionCurrentPT
2/25/21HC Wainwright & Co.MaintainsBuy124.0
1/22/21BarclaysMaintainsOverweight92.0
1/19/21HC Wainwright & Co.MaintainsBuy101.0
12/28/20HC Wainwright & Co.ReiteratesBuy87.0
10/29/20HC Wainwright & Co.MaintainsBuy73.0
8/13/20WedbushMaintainsOutperform50.0
5/13/20WedbushMaintainsOutperform48.0
5/05/20BarclaysInitiates Coverage OnOverweight48.0
4/14/20H.C. WainwrightMaintainsBuy58.0
3/19/20H.C. WainwrightUpgradesBuy60.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter